gayety.com /2 days ago

HIV Vaccine: Why There Isn’t One Yet, and What Comes Next

There's still no HIV vaccine. See why Mosaico and other big trials failed, what 2025 mRNA germline-targeting studies found and how the PrEP shot differs.

Read source
newzimbabwe.com /1 month ago

New hope for TB prevention in people with HIV as experimental vaccine deemed safe

THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for...

Read source
healio.com /1 month ago

Third dose of HepB-CpG may boost immunity for people with HIV

NASHVILLE, Tenn. — Two doses of hepatitis B virus vaccine with CpG adjuvant may not be sufficient for people with HIV who do not respond to an initial vaccination series, according...

Read source
africanews.com /4 weeks ago

HIV prevention jab offers hope in Uganda but doses are hard to find

An injectable HIV drug could save huge numbers of people from getting infected in Uganda.
But shortages of lenacapavir mean that those who need it the most often can't get treate...

Read source
wcpo.com /2 weeks ago

Approval of a generic HIV-prevention shot raises hopes in low-income countries

The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensivel...

Read source
sciencealert.com /3 weeks ago

One Dose of Experimental Antibody Kept HIV-Like Virus in Remission For 4 Years in a Monkey

"May be a surprisingly effective route to HIV cure."ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

Read source
thehindubusinessline.com /2 weeks ago

Dr Reddy’s injectable lenacapavir for HIV prevention gets tentative nod from USFDA

The first supplies are expected to reach people by the end of 2026, with broader rollout across eligible countries expected in 2027

Read source
mckoysnews.com /2 weeks ago

US FDA Grants Tentative Approval for $40-a-Year HIV Prevention Shot

A lower-cost version of the twice-yearly HIV prevention injection lenacapavir has received tentative approval from […] The post US FDA Grants Tentative Approval for $40-a-Year HIV...

Read source
genengnews.com /2 weeks ago

HIV-Blocking Antibody Shows Promise, but Resistant Strains Break Through

A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections as antibody levels decline, highlighting...

Read source
discovermagazine.com /3 weeks ago

An Experimental Antibody Kept HIV’s Monkey Counterpart in Remission for up to Four Years

Learn how a single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.

Read source
washingtontimes.com /2 weeks ago

Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries

The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV - a big step toward making the drug available inexpensivel...

Read source
263chat.com /1 month ago

Zimbabwe Gears Up for Nationwide Rollout of Twice-Yearly HIV Jab

About 4,700 people have already started using the injection across 12 sites since February, with officials recording around 500 new initiations each week. The post Zimbabwe Gears U...

Read source
drugs.com /1 month ago

New Drug Combo Restores HIV Control

FRIDAY, Oct. 9, 2026 — A new long-acting drug combo can restore control over HIV for patients whose virus has developed resistance to commonly used medications, researchers report...

Read source
mwananchi.co.tz /3 weeks ago

Utafiti mpya waibua matumaini ya kudhibiti VVU bila ARV

Utafiti mpya wa kisayansi umeibua matumaini katika mapambano dhidi ya Virusi Vya Ukimwi (VVU), baada ya kubaini kuwa kingamwili maalumu zinaweza kuchelewesha kwa kiasi kikubwa kure...

Read source
washingtontimes.com /2 weeks ago

A promising new drug could turn the tide against HIV. But it is hard to find where it's needed most

In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa Mutoni insists on using condoms when men enter her room, to pr...

Read source
thehindubusinessline.com /6 days ago

Use available Ebola vaccine without delay: Médecins Sans Frontières

As vaccine against Bundibugyo Ebola virus is still under development, calls grow for use of ERVEBO to protect more people at risk today

Read source
allafrica.com /2 weeks ago

Nigeria: Cheap Version of Breakthrough HIV Prevention Shot Approved

[Daily Trust] The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in lo...

Read source
allafrica.com /1 month ago

Africa: New TB Vaccines Could Save Millions, but Africa Must Prepare Now

[allAfrica] More than a century after the BCG vaccine was licensed, new tuberculosis vaccines could arrive in 2029. Gavi says the groundwork has to start now.

Read source
allafrica.com /1 month ago

Congo-Kinshasa: Ebola Vaccine Trials 'Reason for Hope' in DR Congo and Beyond

[RFI] Five months into the Ebola outbreak in the Democratic Republic of Congo, there is still no approved vaccine against the rare Bundibugyo strain that has now caused more than 4...

Read source
theeastafrican.co.ke /1 month ago

Uganda trials Ebola vaccine as countries rush to tame spread

Phase One trial involves an experimental vaccine candidate known as ChAdOx1 BDBV. It's being conducted by Ugandan researchers alongside colleagues from London and University of Oxf...

Read source
scmp.com /4 weeks ago

Congo begins Ebola vaccine trial despite embedded outbreak

A pivotal trial of vaccines against the strain of Ebola that is driving a deadly outbreak across parts of Africa has begun in the Democratic Republic of Congo, where the epidemic o...

Read source
parkinsonsnewstoday.com /1 month ago

Trial of experimental Parkinson’s vaccine shows positive initial results

ACI-7104, AC Immune’s experimental vaccine for early Parkinson’s disease, was generally safe and triggered an immune response against aggregated alpha-synuclein, according to resul...

Read source
premiumtimesng.com /4 weeks ago

DRC begins new vaccine trial as outbreak kills over 4,600

The trial, named Tumaini, which means “hope” in Swahili, will assess vaccine candidates designed to protect against the Bundibugyo virus, for which no vaccine has been approved The...

Read source
oxfordmail.co.uk /1 month ago

Oxford-developed Ebola vaccine administered to volunteers in Uganda

Ugandan participants in a clinical safety study received an Oxford-developed Ebola vaccine last week.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.